期刊名称:STEM CELLS AND DEVELOPMENT
ISSN: | 1547-3287
|
出版频率: | Semi-monthly
|
出版社: | MARY ANN LIEBERT, INC, 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, USA, NY, 10801
|
出版社网址: | http://www.liebertpub.com
|
期刊网址: | http://www.liebertpub.com/scd
|
影响因子: | 3.272 |
主题范畴: | CELL & TISSUE ENGINEERING; HEMATOLOGY; MEDICINE, RESEARCH & EXPERIMENTAL; TRANSPLANTATION |
期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
Stem Cells and Development focuses on stem cells of all tissue types and their potential therapeutic applications. The Journal continues its tradition of providing a forum for animated discussion of contentious issues in conventional medicine.
Stem Cells and Development covers: controversial issues on stem cell research; stem cells of all tissues and organs; embryogenesis and adult counterparts of this process; physical processes linking stem cells, primary cell function, and structural development; transition from genes to physical effects: hypotheses and data; development of vasculature, CNS, the endoderm and tetoderm, and defects; processes included in development: how the molecules work; pluripotentiality of adult stem cells; the role of various mediators and how genetic factors affect development at a physical level; correspondence and concise, comprehensive reviews.
标题历史记录详细信息
Former titles (until 2004): Journal of Hematotherapy & Stem Cell Research (美国) (1525-8165) |
(until 1999): Journal of Hematotherapy (美国) (1061-6128) |
Instructions to Authors
Stem Cells and Development welcomes papers covering widely diverse aspects of hematology, bone marrow transplantation, immune reconstitution, and progenitor cell biochemistry and characterization. Stem Cells and Development is particularly committed to providing authors comprehensive yet rapid evaluation of original reports describing developments in hematopoietic progenitor cell processing, purging, identification, expansion, biochemistry, molecular biology, and engraftment. Reports describing the results of basic research, technical advances, and clinical studies are within the scope of Stem Cells and Development. Stem Cells and Development will publish the following types of contributed papers:
Comprehensive Reviews are appraisals of research and clinical trials in fields of current interest. While these are subject to the same review process as other papers, authors are encouraged to speculate about future therapeutic promise of new procedures and techniques. Unsolicited reviews are welcome. Authors of review papers should consult with the Editor-in-Chief about the content and scope of an envisioned review prior to submission of their manuscript.
Cutting Edge Communications are brief, original reports of significant advances that merit accelerated processing and publication. Authors should submit their papers to the Editor-in-Chief, along with a letter outlining the reasons that the work is thought to fall within this category. If the editor agrees that the manuscript potentially provides valuable new information that clearly merits rapid dissemination, processing will be expedited. Otherwise, the manuscript will be processed as a regular submission.
Original Research Reports are full-length descriptions of original research in all fields of hematotherapy and progenitor cell biology. The investigation may focus on basic science, clinical outcomes, or applications of hematotherapy, bone marrow progenitor cell processing, and bone marrow transplantation. Processing of these papers will be expedited, and every effort will be made to provide fast turnaround times and to avoid undue delays in the reviewing process.
Technology Reports briefly and succinctly describe improvements or helpful modifications in procedures used for processing, purging, characterizing, and culturing hematopoietic progenitors and other tissues of interest. These will be reviewed by hematopoietic processing laboratory professionals, who are appropriately represented on Stem Cells and Development's Editorial Advisory Board.
Rapid Communications are papers of extreme interest which are considered for accelerated processing at the author’s request. Authors should contact the editor-in-chief prior to submission of such papers.
Correspondence will provide a forum for presentation of preliminary clinical results, advances in technology, and case reports. In addition, letters extending, contesting, challenging, or disputing claims advanced in previous publications are encouraged and will be submitted to the original authors for comment.
Presentation Manuscripts submitted to Stem Cells and Development will not be rejected solely on the basis of errors in sentence construction, syntax, and grammar. Stem Cells and Development strives to communicate meritorious research from all countries, and reviews will not be compromised due to deficiencies in presentations. However, manuscripts which require substantial editing may, at the authors?discretion, be referred to an editorial service for a nominal fee. Please contact the Editor-in-Chief for details.
Manuscript Submission and Copyright Agreement Form
The Copyright Agreement form (available from web site at http://www.liebertpub.com/media/content/transfer_of_copyright.pdf) should be submitted once your paper has been accepted for publication. Manuscripts cannot be published without this form. The corresponding author is responsible for obtaining signatures of coauthors. Authors not permitted to release copyright must still return the form signed under the statement of the reason for not releasing the copyright. Upon acceptance of your paper, please fax the Copyright Agreement form to 914-740-2108.
Submission of Manuscripts
Three complete copies of the manuscript must be provided; these will not normally be returned. Authors should submit manuscripts to the Editor-in-Chief: Denis English, Ph.D.; Center of Excellence for Aging and Brain Repair, Department of Neurosurgery, University of South Florida College of Medicine, 12901 Bruce B. Downs Blvd., MDC 78, Tampa, Florida, 33612. Tel.: 813-489-4795, Fax: 813-974-3078; e-mail: dkenglish@msn.com European authors may submit their manuscripts to the European Editor: Philippe Hénon, M.D., IRHT, Hôpital du Hasenrain 87, Avenue d?Altkirch 68100, Mulhouse, France; tel. 33 (0) 3 89 64 74 18; fax 33 (0) 3 89 64 78 87. Manuscripts may also be submitted to any associate editor of the Journal. Authors must include a letter of transmittal that includes the paper’s title, corresponding author’s name, address, institutional affiliation(s), a working telephone and fax number, including the country and city code, and e-mail address, processing requests, and a brief rendition of the paper’s major points and importance. The covering letter should include acknowledgment of the fact that the work has not previously been published, is not under consideration for publication elsewhere, and that all authors have read and agree with the contents of the submission and that all authors have contributed substantially to the work.
Authors are encouraged to supply the names, addresses, and fax numbers of 3? individuals who are considered qualified to review the submitted material, as well as the names of individuals whom the authors would prefer not be included in the review process along with the reason for this request. Authors may also request that their manuscripts be directed to specific members of the Editorial Board.
Preliminary processing of manuscripts will be finished within 6 weeks of receipt at the Indianapolis Editorial Office. Authors may wish to take advantage of the 2-week rapid peer review guarantee, wherein for a fee of $150.00, the preliminary processing of the manuscript will be completed within 2 weeks of receipt. Payment can be made by check or money order made out to Stem Cells and Development or by credit card (Master Card or Visa, only), giving the name, address, card number, and expiration date, along with written, signed permission to invoice the card for $150.00 (U.S. currency).
Preparation of Manuscripts Manuscripts must be double-spaced on letter-size (A4) (8 1/2 x 11) white bond paper, with margins of 2.5 cm on each side, and ample space on top and bottom. Submit the original and three copies, including original illustrations, figures, and tables. Disk submission is required, and the disk must match the hard copy exactly. Disks may be submitted in either PC or Macintosh formats, preferably in Microsoft Word or Word Perfect. Please identify the title and authors of the manuscript, its major contribution, suggested reviewers, and other factors as discussed previously. Electronic submission, especially as .pdf files, will facilitate and accelerate the processing of your manuscript.
Electronic submission of art is acceptable with the following caveats:
Do not include any illustrations as part of your text file. Do not prepare any figures in Word as they are not workable. Line illustrations must be submitted at 1200 DPI. Halftones and color photos should be submitted at a minimum of 300 DPI. Adobe is the preferred software. Avoid submitting Power-Point files. Save art as either TIFF or EPS files. Avoid submitting JPEG files. Color art must be saved as CYMK—not RGB. Please provide a laser printout of the art to ensure accuracy. Manuscripts that the editors, in consultation with members of the editorial board, determine not to fit within the scope of the Journal or do not significantly further previously published information will be returned without review. Authors are encouraged to fax the title, authors, institutional affiliation, and either an abstract or a description of the study to be submitted either to the Editor-in-Chief or the European Editor for a prior determination of the potential acceptability of the material to be submitted. Pages should be numbered consecutively. Standard abbreviations may be used. Begin each section on a new page. Please keep all submissions as brief as possible.
Sequence of Sections Title page must contain: a) the complete title of the paper; b) the full name, full mailing address, full contact information (telephone, fax, and e-mail address), and affiliations of each author. Please include the address(es) either on the title page of your paper or on a separate sheet; c) a brief running title; d) the corresponding author’s complete contact information including address and working fax number and/or e-mail address.
Footnotes and abbreviations: List information such as prior conference presentation of the submitted material and a list of non-standard abbreviations (approved abbreviations need not be listed).
Abstract: 250 words or less, without the use of subheadings.
Introduction: Describe the background leading to the study and clearly state the purpose of the study or its major contribution.
Materials and Methods: Provide sufficient information to permit both reproduction of the results by other investigators and appropriate critical evaluation of the procedures used.
Results.
Discussion: The results and discussion sections of short papers may be combined for more effective presentation.
Acknowledgments: State funding sources and other assistance that were necessary for the conduct of the study.
References should be cited in the text and listed numerically at the end of the paper in the order of citation, as detailed in instructions below.
Figure legends: These may be double-spaced under a clear copy of each figure to enhance presentation.
Tables: Number these consecutively throughout the text.
Figures and Tables One original set of figures (clear laser or glossy prints) must accompany the original copy of each manuscript. These figures may be clearly photocopied over their respective legends in the copies accompanying each submission. Three original copies of gel images, autoradiographs, computer images, photomicrographs, halftones, or other material that reproduces well should be submitted. Please note that while we do not impose page charges or manuscript submission or processing fees, it is necessary to impose a charge for the the reproduction of color photographs and colored items in figures. These charges, which apply to both unsolicited and invited manuscripts, are necessary to keep the subscription price of Stem Cells and Development at its current, reasonable rate, and can only be modified by prior consent of the publisher. Please contact the publisher for current rates. Color costs apply to all manuscripts, including those invited, unless the contributor has made prior arrangements with the publisher. Color prints will be returned upon request.
References (please follow carefully) References may be made to published work and papers in press. Reference citations are not permitted in the abstract of a paper. Authors are responsible for the accuracy of all literature citations. Work in progress, in preparation, unpublished work, and personal communications should be cited as footnotes to the text. References should be listed numerically in the text in the order of appearance as parenthesized consecutive numbers, e.g., (1,2). Where there are more than two references, the citation should appear as hyphenated numbers, e.g., (1?). References should be typed double-spaced in numerical order of citation, with all authors listed. Abbreviations of journals should conform to those used in Medline. The following formats must be used:
Journal papers
Buckner CD, RB Epstein, RH Rudolph, RA Clift, R Storb and ED Thomas. (1970). Allogeneic marrow engraftment following whole body irradiation in a patient with leukemia. Blood 35:741?50. Shadduck RK, A Warheed, F Boegel, G Pigoli, A Porcellini and V Rizzoli. (1987). The effect of colony stimulating factor-1 in vivo. Blood Cells 13:49?3. Wang XS, MC Yoder, SZ Zhou and A Srivastava. (1995). Parvovirus B19 promoter at map unit 6 confers autonomous replication competence and erythroid specificity to adeno-associated virus 2 in primary human hematopoietic pro-genitor cells. Proc Natl Acad Sci (USA) 92:12416?2420. Book
Gee AP, ed. Bone Marrow Purging and Processing: A Practical Guide. (1991). CRC Press, Boca Raton, FL. Book chapter
Hénon P. (1993). Clinical aspects of autologous blood stem cell transplantation. Review of indications. In: Peripheral Blood Stem Cell Autografts. E Wunder and P Henon, eds. Springer-Verlag, Heidelberg, pp 209?40. Permissions Written permission must be obtained from the publisher of the journal or book concerned for the reproduction of figures, tables, etc. from copyrighted materials.
The publication from which the figure or table is taken must be listed in the reference list.
A footnote of a reprinted table, or of the legend of a reprinted figure, should read, “Reprinted with permission from Jones et al.?and list the appropriate reference.
Copyright Unless rejected for publication, all submissions become the property of Mary Ann Liebert, Inc., Publishers. By submitting their work for review by Stem Cells and Development, all authors and co-authors acknowledge transfer of the copyright of their submission to Mary Ann Liebert, Inc. Such copyright shall automatically revert to the author(s) if the paper is withdrawn prior to the time when the paper is typeset for publication or if the paper is not accepted for publication. While no part of any publication may be reproduced in any form without written consent of the publisher and credit to the original material, such consent shall not unreasonably be denied. Consent can be obtained by contacting the editor-in-chief.
Reprints Order reprints using the order form that will accompany the proofs. Reprints ordered after the issue is printed will be charged at a higher rate.
Publisher Stem Cells and Development is published by Mary Ann Liebert, Inc., 140 Huguenot Street, 3rd Floor, New Rochelle, NY 10801-5215. Telephone: (914) 740?100; fax: (914) 740?108.
Editorial Board
Editor-in-Chief
Denis English, Ph.D. Center of Excellence for Aging and Brain Repair Department of Neurosurgery University of South Florida College of Medicine 12901 Bruce B. Downs Blvd. MDC 78 Tampa, Florida, 33612 Tel: (813) 489-4795 Fax: (813) 974-3078 dkenglish@msn.com
Senior Editors
Hal E. Broxmeyer, Ph.D. Indiana University School of Medicine 1044 West Walnut Street Indianapolis, IN 46202-5254 Tel: (317) 274-7510 Fax: (317) 274-7592 hbroxmey@iupui.edu
Joe G.N. Garcia, M.D. Chairman, Department of Medicine Pritzker School of Medicine University of Chicago 5841 S. Maryland Avenue Chicago, Illinois 60637-1470 Fax: 773/702-4427 Phone: 773/702-1051 E-mail: jgarcia@medicine.bsd.uchicago.edu
Associate Editors
Jos?R. Borbolla-Escoboza, M.D. Institute for Technological and Superior Studies Monterrey, Mexico borbolla@itesm.mx
Ursula M. Gehling, M.D. University Hospital Hamburg-Eppendorf Hamburg, Germany gehling@uke-uni-hamburg.de
Eberhard Gunsilius, M.D. University Hospital Innsbruck, Austria eberhard.gunsilius@uibk.ac.at
Ralf Huss, M.D. Roche Diagnostics GmbH ralf.huss@roche.com
Christopher G. Janson, M.D. Robert Wood Johnson Medical School (UMDNJ) Camden, NJ jansoncg@umdnj.edu
Vaijayanti P. Kale, Ph.D. National Center for Cell Science Pune, India. vpkale@nccs.res.in
Graham C. Parker, Ph.D. Children's Research Center of Michigan Detroit gparker@med.wayne.edu
Domenico Ribatti, M.D. University of Bari Medical School Bari, Italy ribatti@anatomia.uniba.it
Paul R. Sanberg, Ph.D., D.Sc. University of South Florida College of Medicine Tampa psanberg@hsc.usf.edu
David S. Strayer, M.D., Ph.D. Jefferson Medical College Philadelphia david.strayer@jefferson.edu
Mervin C. Yoder, Jr., M.D. Wells Center for Pediatric Research Indianapolis myoder@iupui.edu
Robert Zhao, M.D., Ph.D. Chinese Academy of Medical Sciences Beijing, China stemcell@public.tpt.tj.cn
Barry L. Ziober, Ph.D. University of Pennsylvania bziober@mail.upenn.edu
Editorial Board
Edward D. Ball, M.D. UCSD Cancer Center La Jolla, CA
Edward J. Benz, Jr., M.D. Dana Farber Cancer Institute Boston
Claudio Bordignon, M.D. Instituto Scientifico Milan
Laurence A. Boxer, M.D. University of Michigan Medical Center Ann Arbor
Richard E. Champlin, M.D. M.D. Anderson Cancer Center
D. Wade Clapp, M.D. Cancer Research Institute Indianapolis
H. Joachim Deeg, M.D. University of Washington School of Medicine Seattle
Taner Demirer, M.D. Ankara University Medical School Ankara, Turkey
Yair Gazitt, Ph.D. University of Texas Health Science Center San Antonio, TX
Stefan Glück, M.D., Ph.D. University of Miami
Elaine Gluckman, M.D. Hopital St. Louis Paris
James D. Griffin, M.D. Harvard Medical School Boston
Rainer Haas, M.D., Ph.D. University of Düsseldorf Düsseldorf, Germany
Hans Johnsen, M.D. University of Copenhagen
Armand Keating, M.D. Toronto Hospital
Paul Kincade, Ph.D. Oklahoma Medical Research Foundation Oklahoma City
H. Phillip Koeffler, M.D. Cedars-Sinai Medical Center Los Angeles
Peter Lansdorp, M.D., Ph.D. British Columbia Cancer Agency Vancouver
Tsvee Lapidot, Ph.D. Weizmann Institute of Science Rehovot, Israel
Massimo Martelli, M.D. Policlinico Monteluce Perugia, Italy
Eva Mezey, M.D., Ph.D. National Institute of Neurological Disorders and Stroke Bethesda, MD
Alan M. Miller, M.D., Ph.D. Tulane University New Orleans
Jeffrey S. Miller, M.D. University of Minnesota
Keisuke Miyazawa, M.D. Tokyo Medical College
Malcolm A.S. Moore, D.Phil. Memorial Sloan-Kettering Cancer Center
Suneel D. Mundle, Ph.D. Rush Cancer Institute
Stefan Przyborski, Ph.D. University of Durham Durham, UK
Shahin Rafii, M.D. Cornell University Medical College
Mahendra Rao, M.D., Ph.D. National Institute of Aging Baltimore, MD
Yair Reisner, Ph.D. The Weizmann Institute of Science Rehovot, Israel
Maria T. Rizzo, M.D. Methodist Research Institute Indianapolis
Friedrich G. Schuening, M.D. Vanderbilt University Medical Center Nashville
Charles N. Serhan, Ph.D. Brigham and Women's Hospital/Harvard Medical School Boston
Richard K. Shadduck, M.D. Western Pennsylvania Cancer Institute Pittsburgh
Shimon Slavin, M.D. Hadassah University Hospital Jerusalem
Franklin O. Smith, M.D. Children's Hospital Medical Center Cincinnati, OH
Gerald J. Spangrude, Ph.D. University of Utah Medical Center
Edward F. Srouer, Ph.D. Indiana Cancer Research Institute Indianapolis
Leon W.M.M. Terstappen, M.D., Ph.D. Immunicon Corporation Huntingdon Valley, PA
Leun Bik To, M.D. Institute of Medical and Veterinary Science Adelaide, Australia
John Wagner, M.D. University of Minnesota Minneapolis
|